skip to search skip to navigation skip to main content

Archive: January 2016

Changing Tomorrow Day – Astellas volunteers in community service projects in the region

27th January 2016 in Corporate Social Responsibility

Dubai, United Arab Emirates; 27 January 2016: As part of its Changing Tomorrow initiative, Astellas MENA/SSA employees conducted community service activities across the region. Team members in Algeria, Egypt, Iran, Jordan, KSA, Lebanon, and the UAE spread hope and joy to the people within the establishments they supported. Commenting on the collaborated regional community outreach,…

Read Full Post

Vesicare Launch in Algeria

16th January 2016 in Product Launches

Algiers, Algeria 10 September 2015. Astellas Middle East, North and Sub-Saharan Africa (MENA/SSA) announced that a new treatment, Solifenacin succinate, has been made available in Algeria for relieving symptoms of overactive bladder (OAB) in adults.1 This includes patients suffering from a strong, sudden urge to urinate without prior warning and having to urinate frequently.1 This…

Read Full Post

Betmiga launched in Jordan

13th January 2016 in Product Launches

Amman, Jordan; January 13, 2016: Astellas Pharma Middle East, North and Sub-Saharan Africa (MENA/SSA), today announced that a new treatment for relieving symptoms of overactive bladder (OAB) is now available in Jordan. The treatment contains the active ingredient mirabegron, providing a new and alternative treatment option to conventional antimuscarinics treatment for adult patients. OAB is…

Read Full Post

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2019 Astellas Pharma